Diagnostic utility of testing for antineutrophil cytoplasmic antibodies

Chetan B. Mukhtyar

doi:10.20452/pamw.16224

Diagnostic utility of testing for antineutrophil cytoplasmic antibodies

Chetan B. Mukhtyar

Norwich Medical School

Research output: Contribution to journal › Editorial › peer-review

3 Downloads (Pure)

Abstract

Antineutrophil cytoplasmic antibodies (ANCA) that target the third neutral serine proteinase (PR3) and myeloperoxidase (MPO) of human neutrophils are associated with primary systemic vasculitis that predominantly affects small and medium blood vessels.1,2 There is an international consensus that testing for ANCA should specifically be focused on identifying antibodies against those 2 antigenic targets.3 In this edition of the journal, Wójcik et al4 discuss the data from the Polish Vasculitis Register (POLVAS) including information from 536 individuals who presented with vasculitis over 27 years, in the demographic context.

Original language	English
Article number	16224
Journal	Polskie Archiwum Medycyny Wewnetrznej
Volume	132
Issue number	3
DOIs	https://doi.org/10.20452/pamw.16224
Publication status	Published - 30 Mar 2022

Access to Document

10.20452/pamw.16224Licence: CC BY-NC-SA

inv_ed_MukhtyarFinal published version, 89.3 KBLicence: CC BY-NC-SA

https://www.mp.pl/paim/issue/article/16224Licence: CC BY-NC-SA

Cite this

@article{6063626c443d451b823c6231769401c1,

title = "Diagnostic utility of testing for antineutrophil cytoplasmic antibodies",

abstract = "Antineutrophil cytoplasmic antibodies (ANCA) that target the third neutral serine proteinase (PR3) and myeloperoxidase (MPO) of human neutrophils are associated with primary systemic vasculitis that predominantly affects small and medium blood vessels.1,2 There is an international consensus that testing for ANCA should specifically be focused on identifying antibodies against those 2 antigenic targets.3 In this edition of the journal, W{\'o}jcik et al4 discuss the data from the Polish Vasculitis Register (POLVAS) including information from 536 individuals who presented with vasculitis over 27 years, in the demographic context.",

author = "Mukhtyar, {Chetan B.}",

year = "2022",

month = mar,

day = "30",

doi = "10.20452/pamw.16224",

language = "English",

volume = "132",

journal = "Polskie Archiwum Medycyny Wewnetrznej",

issn = "0032-3772",

publisher = "Medycyna Praktyczna",

number = "3",

}

TY - JOUR

T1 - Diagnostic utility of testing for antineutrophil cytoplasmic antibodies

AU - Mukhtyar, Chetan B.

PY - 2022/3/30

Y1 - 2022/3/30

N2 - Antineutrophil cytoplasmic antibodies (ANCA) that target the third neutral serine proteinase (PR3) and myeloperoxidase (MPO) of human neutrophils are associated with primary systemic vasculitis that predominantly affects small and medium blood vessels.1,2 There is an international consensus that testing for ANCA should specifically be focused on identifying antibodies against those 2 antigenic targets.3 In this edition of the journal, Wójcik et al4 discuss the data from the Polish Vasculitis Register (POLVAS) including information from 536 individuals who presented with vasculitis over 27 years, in the demographic context.

AB - Antineutrophil cytoplasmic antibodies (ANCA) that target the third neutral serine proteinase (PR3) and myeloperoxidase (MPO) of human neutrophils are associated with primary systemic vasculitis that predominantly affects small and medium blood vessels.1,2 There is an international consensus that testing for ANCA should specifically be focused on identifying antibodies against those 2 antigenic targets.3 In this edition of the journal, Wójcik et al4 discuss the data from the Polish Vasculitis Register (POLVAS) including information from 536 individuals who presented with vasculitis over 27 years, in the demographic context.

UR - http://www.scopus.com/inward/record.url?scp=85127234137&partnerID=8YFLogxK

U2 - 10.20452/pamw.16224

DO - 10.20452/pamw.16224

M3 - Editorial

VL - 132

JO - Polskie Archiwum Medycyny Wewnetrznej

JF - Polskie Archiwum Medycyny Wewnetrznej

SN - 0032-3772

IS - 3

M1 - 16224

ER -

Diagnostic utility of testing for antineutrophil cytoplasmic antibodies

Abstract

Access to Document

Other files and links

Cite this